Li C, He Q, Qian H, Liu J. Overview of the pathogenesis of COVID 19 (Review). Exp Ther Med. 2021;22:1011.Search in Google Scholar
Barciszewska AM. Elucidating of oxidative distress in COVID-19 and methods of its prevention. Chemico Biol Interact. 2021;344:109501.Search in Google Scholar
Ntyonga-Pono MP. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment. Pan Afr Med J. 2020;35:12.Search in Google Scholar
Gadotti AC, Lipinski AL, Vasconcellos FT, et al. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic Biol Med. 2021;165:184-190.Search in Google Scholar
Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytok Growth Fact Rev.2020;54:62–75.Search in Google Scholar
Laforge M, Elbim C, Frère C, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20:515–516.Search in Google Scholar
Pincemail J, Cavalier E, Charlier C, Cheramy– Bien JP, Brevers E, Courtois A, et al. Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants. 2021;10:257.Search in Google Scholar
Atanasovska E, Petrusevska M, Zendelovska D, et al. Vitamin D levels and oxidative stress markers in patients hospitalized with COVID-19. Redox Rep. 2021;26:184-189.Search in Google Scholar
Zendelovska D, Atanasovska E, Petrushevska M, et al. Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19. Rom J Intern Med. 2021;59:375-383.Search in Google Scholar
Petrushevska M, Zendelovska D, Atanasovska E, et al. Presentation of cytokine profile in relation to oxidative stress parameters in patients with severe COVID-19: a case-control pilot study. F1000Res. 2021;10:719.Search in Google Scholar
de Las Heras N, Martín Giménez VM, Ferder L, et al. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D. Antioxidants. 2020;9:897.Search in Google Scholar
Carpagnano GE, Di Lecce V, Quaranta VN, et al. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest. 2021;44:765-771.Search in Google Scholar
D’Avolio A, Avataneo V, Manca A, et al. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients. 2020;12:1359.Search in Google Scholar
Cuadrado A, Pajares M, Benito M, et al. Can activation of NRF2 be a strategy against COVID-19? Trends Pharmacol Sci. 2020;41:9.Search in Google Scholar
Gasparello J, D’Aversa E, Papi C, Gambari L, Grigolo B, et al. Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein. Phytomedicine. 2021;87:153583.Search in Google Scholar
Bousquet J, Le Moing V, Blain H, et al. Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases. World Allergy Organ J. 2020;14(1):100498.Search in Google Scholar
Mahn A, Castillo A. Potential of sulforaphane as a natural immune system enhancer: A review. Moecules.2021;26:752.Search in Google Scholar
Kow CS, Ramachandram DS, Hasan SS. Use of sulforaphane in COVID-19: Clinical trials are needed. Mol Immunol. 2022;145:78-79.Search in Google Scholar
Ter Ellen BM, Kumar ND, Bouma EM, et al. Resveratrol and Pterostilbene Inhibit SARSCoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells. Viruses.2021;13:1335.Search in Google Scholar
Liao MT, Wu C, WU SV, et al. Resveratrol as an adjunctive therapy for excessive oxidative stress in aging COVID-19 patients. Antioxidants.2021;10:1440.Search in Google Scholar
Filardo S, Di Pietro M, Mastromarino P, Sessa R. Therapeutic potential of resveratrol against emerging respiratory viral infection. Pharmacol Therap. 2020;214:107613.Search in Google Scholar
Rahmadani LH, Bachari K. Potential therapeutic effects of resveratrol against SARS-CoV-2, Acta virol. 2020;64:276-280.Search in Google Scholar
Xiao Z, Ye Q, Duan X, Xiang T. Network pharmacology reveals that resveratrol can alleviate COVID-19 related hyperinflammation, Dis Markers. 2021;4129993.Search in Google Scholar
Pasquereau S, Nehme Z, Haidar Ahmad S, et al. Resveratrol Inhibits HCoV-229E and SARSCoV-2 Coronavirus Replication In Vitro. Viruses. 2021;23:354.Search in Google Scholar
Seo DJ, Choi C. Antiviral bioactive compounds of mushrooms and their antiviral mechanisms: a review. Viruses. 2021;13:50.Search in Google Scholar
Hetland G, Johnson E, Bernardshaw SV, Grinde, B. Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation. Scand J immunol. 2020;00:12937.Search in Google Scholar
Shahzad F, Anderson D, Najafzadeh M. The antiviral, anti-inflammatory effects of natural medicinal herbs and mushrooms and SARS-CoV-2 infection. Nutrients. 2020;12:2573.Search in Google Scholar
Suwannarach N, Kumla J, Sujarit K, et al. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses. Molecules. 2020;25;1800.Search in Google Scholar
Gracian-Alcaide C, Maldonado-Lobon JA, Ortiz-Tikkakoski E, et al. Effects of a combination of elderberry and reishi extracts on the duration and severity of respiratory tract infections in elderly subjects: A randomized controlled trial. Appl Sci. 2020;10:8259.Search in Google Scholar
Habashy NH, Abu-Serie MM. The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking. J Funct Foods. 2020;75:104282.Search in Google Scholar
Ismail NF, Zulkifli MF, Ismail WIW. Therapeutic potentials of bee products for treatment of COVID-19. IMJM Med J Malaysia. 2021;21.Search in Google Scholar
Lima WG, Brito JCM, da Cruz Nizer WS. Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2), Phytother res. 2020;1-8.Search in Google Scholar
Todorovic N, Djordjevic N, Pajovic SB. In vitro analyses of antioxidant activity of food supplements GE Kids and Ge132+ Natural™, J Food Nutr Res. 2019;7:355-360.Search in Google Scholar
Immunomodulatory and antioxidant activities of Ge132+ Natural™ ™, VivaCell Biotechnology GmbH (2012) (unpublished results).Search in Google Scholar
Ho HPT, Vo DNK, Lin TY, et al. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion. Biomed Pharmacother. 2022;155:113766.Search in Google Scholar
Cör Andrejč D, Knez Ž, Knez Marevci M. Anti-oxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum: An overview. Front Pharmacol. 2022;13:934982.Search in Google Scholar
Ordonez AA, Bullen CK, Villabona-Rueda AF, et al. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Commun Biol. 2022;5(1):242.Search in Google Scholar
McCreary MR, Schnell PM, Rhoda DA. Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Out-patient Treatment of Mild Coronavirus Disease (COVID-19). Res Sq [Preprint]. 2021;861831.Search in Google Scholar
van Brummelen R, van Brummelen AC. The potential role of resveratrol as supportive anti-viral in treating conditions such as COVID-19 - A formulator’s perspective. Biomed Pharmacother. 2022;148:112767.Search in Google Scholar
Khongthaw B, Dulta K, Chauhan PK, et al. Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID-19). Inflammopharmacology.2022;1–22.Search in Google Scholar
